AF
NBSE

Advisornet Financial’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Advisornet Financial’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Hold
0
– – – 1851
2020
Q4 		– Hold
0
– – – 1871
2020
Q3 		– Sell
-2
Closed -$326 – 1909
2020
Q2 		$0 Buy
+2
New +$335 ﹤0.01% 1956

Other funds holding NBSE

GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JAMONY
Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Advisornet Financial's NBSE Position: Q1 2021 in Review

Advisornet Financial held its NeuBase Therapeutics, Inc. Common Stock (NBSE) position steady in Q1 2021 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1851.

Advisornet Financial first reported a position in NBSE in Q2 2020 and has held it in 1 quarter since. The position peaked at $0 in Q2 2020. 56 funds tracked by Wall St. Rank hold NBSE as of Q1 2021.

  • Advisornet Financial held 0 shares of NeuBase Therapeutics, Inc. Common Stock worth $0 as of Q1 2021.
  • Advisornet Financial left its NeuBase Therapeutics, Inc. Common Stock share count unchanged in Q1 2021.
  • NeuBase Therapeutics, Inc. Common Stock made up ﹤0.01% of Advisornet Financial's portfolio in Q1 2021, its #1851 holding.
  • Advisornet Financial first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q2 2020 and has held it in 1 quarter since.
  • Advisornet Financial's NeuBase Therapeutics, Inc. Common Stock position peaked at $0 in Q2 2020.
  • 56 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Advisornet Financial's 13F filing for Q1 2021, filed 14 Apr 2021.